The Lowy Medical Research Institute is releasing the summary of its Annual Meeting, which LMRI hosted May 11-12, 2018.
The primary purpose of this meeting was the exchange of information and ideas between stakeholders involved in macular telangiectasia type 2 research, primarily work supported by LMRI. The meeting included scientists and clinicians; a representative of the MacTel patient community; members of the Board of Scientific Governors and Board of Directors; and the Project Sponsors, the Lowy Family.
The Annual Meeting included updates on the Natural History Observation Registry Study (NHOR), clinical trials, other clinical research, genetic research, and laboratory research. For more information about the progress LMRI and affiliated researchers and clinicians are making in MacTel research, please review the summary. If you would like more information about participating in clinical research through the registry, clinical trials, or the eye donation program, please contact us (email@example.com).
Read and download the meeting summary here: LMRI Annual Meeting Summary 2018.